Achilles Therapeutics Correlations
| ACHLDelisted Stock | USD 1.48 0.00 0.00% |
The current 90-days correlation between Achilles Therapeutics PLC and Assembly Biosciences is 0.03 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Achilles Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Achilles Therapeutics PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Achilles Therapeutics Correlation With Market
Very good diversification
The correlation between Achilles Therapeutics PLC and DJI is -0.21 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and DJI in the same portfolio, assuming nothing else is changed.
Achilles |
Moving together with Achilles Stock
| 0.66 | MDCX | Medicus Pharma | PairCorr |
| 0.69 | EQ | Equillium | PairCorr |
| 0.89 | VALN | Valneva SE ADR | PairCorr |
| 0.69 | MGTX | MeiraGTx Holdings PLC | PairCorr |
| 0.77 | DOMH | Dominari Holdings Earnings Call This Week | PairCorr |
Moving against Achilles Stock
| 0.89 | MDXG | MiMedx Group | PairCorr |
| 0.87 | MGNX | MacroGenics | PairCorr |
| 0.77 | MBIO | Mustang Bio | PairCorr |
| 0.75 | MCRB | Seres Therapeutics | PairCorr |
| 0.7 | VANI | Vivani Medical | PairCorr |
| 0.67 | DNLI | Denali Therapeutics | PairCorr |
| 0.63 | MBRX | Moleculin Biotech Buyout Trend | PairCorr |
| 0.88 | VERA | Vera Therapeutics | PairCorr |
| 0.85 | MLTX | MoonLake Immunotherapeuti | PairCorr |
| 0.85 | MNKD | MannKind Corp Sell-off Trend | PairCorr |
| 0.74 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.68 | VCEL | Vericel Corp Ord | PairCorr |
| 0.68 | VCYT | Veracyte | PairCorr |
| 0.64 | DSGN | Design Therapeutics | PairCorr |
| 0.63 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.59 | DRTS | Alpha Tau Medical | PairCorr |
| 0.5 | VERU | Veru Inc | PairCorr |
| 0.42 | MLEC | Moolec Science SA | PairCorr |
| 0.86 | MRKR | Marker Therapeutics | PairCorr |
| 0.86 | MRVI | Maravai Lifesciences | PairCorr |
| 0.84 | VKTX | Viking Therapeutics | PairCorr |
| 0.82 | MNOV | MediciNova | PairCorr |
Related Correlations Analysis
| 0.86 | 0.32 | 0.0 | 0.87 | 0.87 | 0.79 | ASMB | ||
| 0.86 | 0.16 | 0.0 | 0.83 | 0.87 | 0.65 | SPRO | ||
| 0.32 | 0.16 | 0.0 | 0.37 | 0.33 | 0.3 | TIL | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | NLTX | ||
| 0.87 | 0.83 | 0.37 | 0.0 | 0.87 | 0.75 | NUVB | ||
| 0.87 | 0.87 | 0.33 | 0.0 | 0.87 | 0.81 | CTMX | ||
| 0.79 | 0.65 | 0.3 | 0.0 | 0.75 | 0.81 | NXTC | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Achilles Stock performing well and Achilles Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Achilles Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ASMB | 3.00 | (0.27) | 0.00 | (0.29) | 0.00 | 6.63 | 24.82 | |||
| SPRO | 2.70 | (0.14) | 0.00 | (0.40) | 0.00 | 9.57 | 21.98 | |||
| TIL | 5.70 | (0.02) | 0.00 | 0.00 | 6.04 | 13.25 | 34.30 | |||
| NLTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| NUVB | 3.25 | (0.46) | 0.00 | (0.39) | 0.00 | 6.88 | 28.03 | |||
| CTMX | 3.62 | (0.82) | 0.00 | (0.35) | 0.00 | 7.32 | 17.13 | |||
| NXTC | 3.48 | (0.61) | 0.00 | (0.38) | 0.00 | 6.74 | 21.57 |
Achilles Therapeutics Corporate Management
| Sergio Quezada | Founder Officer | Profile | |
| Daniel Hood | General Secretary | Profile | |
| Tariq Ahmed | Executive People | Profile | |
| James Taylor | Chief Officer | Profile | |
| Julia Wilson | Head Communications | Profile | |
| Lee Stern | Vice Communications | Profile | |
| FMEDSCI MD | Founder | Profile |
Still Interested in Achilles Therapeutics PLC?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.